Delaware Business DE

AstraZeneca's rare disease business, Swiss company strike deal on heart failure drug

Delaware Business Now

Jan 8, 2022

Alexion, AstraZeneca's newly acquired rare disease business, entered into an exclusive global collaboration and license agreement with Swiss-based Neurimmune AG for NI006, an inves…

Read the full story at Delaware Business Now

AstraZeneca's rare disease business, Swiss company strike deal on heart failure drug

More from Delaware Business

Delaware charters pulled for LLC's tied to drug traffickers

Delaware gas prices approach year-ago numbers

Rack Room Shoes opens in Salisbury, and a new pool hall on the way | What's Going There

Suspect dead after carjackings, pursuit by officers in I-95 area

PBF Energy acquires remaining interests in logistics business

My take: Feds take closer look at criminal monopoly actions

ChristianaCare center named in honor of donor and breast cancer survivor Tatiana Copeland

Veteran Business Leader and Communications Specialist to Assume Role of Vice Chair